Sheng-tao Yuan

State Key Laboratory Of Natural Medicines, P.R. China
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Targeting GLS1 to cancer therapy through glutamine metabolism.

I-8, a novel inhibitor of mutant IDH1, inhibits cancer progression in vitro and in vivo.

Showing 1-12 of 34

Last Updated: 09/26/2026